Clinical Trials Logo

Prostate clinical trials

View clinical trials related to Prostate.

Filter by:

NCT ID: NCT02756975 Completed - Complication Clinical Trials

Prostate Core Needle Biopsy

Prostate
Start date: December 2014
Phase: N/A
Study type: Interventional

Prostate tissue biopsy is performed with either transrectal or transperineal approach. These two methods are usually based on tissue sampling with an ultrasound-guided core needle biopsy. Transperineal prostate biopsy can be done either with a conventional noncoaxial technique or with a coaxial technique. In conventional transperineal technique, biopsy needle is inserted repeatedly for each tissue sampling. Alternatively, a coaxial needle can be placed over the perineum; then, the direction of the biopsy can be changed by tilting the coaxial needle. In this prospective study, the investigators sought to compare the procedural time and the complication rate of coaxial technique with those of noncoaxial technique in transperineal prostate biopsy.

NCT ID: NCT01118260 Completed - Prostate Clinical Trials

Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection

TURPS
Start date: January 2006
Phase: Phase 4
Study type: Interventional

Comparison of total intravenous anaesthesia with spinal anaesthesia in patients undergoing transurethral prostate resection

NCT ID: NCT01078662 Active, not recruiting - Prostate Clinical Trials

Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats

Start date: February 21, 2010
Phase: Phase 2
Study type: Interventional

To assess the efficacy of oral olaparib in patients with advanced cancer who have a confirmed genetic BRCA1 and/or BRCA2 mutation, by assessment of tumour response

NCT ID: NCT00923221 Recruiting - Prostate Cancer Clinical Trials

Collection of Blood From Patients With Prostate Cancer

Start date: February 28, 2007
Phase:
Study type: Observational

Background: - It is not fully understood why prostate cancer in some men becomes androgen-independent (no longer responds to anti-androgen medication), but genetics likely plays an important role. - Genes contain the hereditary information that is passed down from parents to children. Although everyone has the same set of genes, individuals can have different forms of the same gene. - Differences in genes may explain, at least in part, why some people develop a more aggressive form of prostate cancer than others. Objectives: -To obtain blood samples from patients with prostate cancer to try to identify gene differences associated with progression to the androgen independent state. Eligibility: -All participants participating in NCI prostate cancer protocols. Design: - Participants with prostate cancer are evaluated in the NCI s Medical Oncology Clinic. - Blood samples are collected at the initial visit or at follow-up visits. - DNA (genetic material) and white blood cells are extracted from these samples to be used for genotyping and establishment of cell lines. - Gene variations are correlated with prostate cancer prognosis and prognostic indicators.

NCT ID: NCT00648323 Completed - Prostate Clinical Trials

Evaluation Of The Efficacy And Safety Of The Doxasozin Gastrointestinal Therapeutic System (GITS) In Patients With Prostate Enlargement

Start date: November 2003
Phase: Phase 4
Study type: Interventional

The primary objectives were to determine the efficacy and safety of the GITS formulation of Doxazosin in Taiwanese patients with prostate enlargement.

NCT ID: NCT00586898 Completed - Cancer Clinical Trials

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Start date: July 2001
Phase: Phase 2
Study type: Interventional

Objective: To determine the response to rapid hormonal cycling in patients with non-castrate prostate cancer.

NCT ID: NCT00579423 Completed - Cancer Clinical Trials

Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer

Start date: November 2000
Phase: Phase 2
Study type: Interventional

This is a pilot trial designed to assess safety and immunogenicity of a multivalent conjugate vaccine for use in patients with biochemically relapsed prostate cancer.

NCT ID: NCT00572468 Active, not recruiting - Cancer Clinical Trials

Statin Therapy Versus Placebo Prior to Prostatectomy

Start date: December 2007
Phase: N/A
Study type: Interventional

This is a randomized trial comparing the effect of oral simvastatin versus placebo on targets of the mevalonate pathway in men undergoing a prostatectomy as planned management for prostate cancer. Observed tissue effects will be correlated with changes in serum cholesterol and low-density lipoprotein.

NCT ID: NCT00547625 Completed - Clinical trials for Prostatic Hyperplasia

Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems

PILUTS
Start date: October 2004
Phase: Phase 2
Study type: Interventional

Study to look at safety and effectiveness of different doses of tadalafil on prostate related genital/urinary tract problems.

NCT ID: NCT00423254 Completed - Gastric Cancer Clinical Trials

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Start date: February 2007
Phase: Phase 1
Study type: Interventional

The present clinical trial is a dose comparison of a multi-component active immunotherapy designed to stimulate an immune reaction to specific tumor associated antigens which are highly expressed on a large number of solid cancers.